Progresses in Nano-Enabled Platforms for the Treatment of Vaginal Disorders

Advanced therapeutic strategies using Thermo-sensitive chitosan/pectin hydrogel in the treatment of multiple cancers

Current cancer therapies including immunotherapy and chemotherapy produce adverse side effects that demand improved drug distribution methods. Research shows that thermosensitive chitosan/pectin-based hydrogels serve as an effective platform technology for drug delivery during cancer therapy because of their ability to control drug release at specific locations. The hydrogels perform temperature-triggered sol-gel phase shifts which enables prolonged drug delivery together with minimal toxic side effects. The biocompatible and biodegradable properties of these materials enable solutions against drug resistance and tumour heterogeneity challenges. Studies have demonstrated that these hydrogels enhance drug bioavailability, extend circulation time, and improve tumour targeting, leading to increased therapeutic efficacy and reduced systemic toxicity. Their ability to sustain drug release and penetrate tumour microenvironments makes them a promising strategy for overcoming drug resistance and tumour heterogeneity. Their ability to reproduce native tissue properties poses challenges that scientists must address through improved structural optimization approaches. The combination of latest nanotechnology innovations and interdisciplinary studies has sped up the creation of chitosan/pectin hydrogels for cancer treatment applications. This review highlights the significant advancements and demonstrated effectiveness of thermosensitive chitosan/pectin hydrogels in cancer treatment by exploring their design parameters alongside their drug release behaviour while discussing their potential medical applications.

An update on selective estrogen receptor modulator: repurposing and formulations

The selective estrogen receptor modulator (SERM) raloxifene hydrochloride (RLH) is used extensively in the management and prevention of breast cancer and osteoporosis. Recent clinical studies show the repurposing of RLH in various diseases based on its structure and some clinical trials studies. Optimizing the clinical effectiveness of this important drug requires a thorough review of the formulation techniques, patent environment, and analytical procedures. The purpose of this study is to give a thorough understanding of dug repurposing with the most recent formulation strategies, patents, and analytical methods related to RLH. Highlighting recent developments, pointing out current issues, and suggesting future lines of inquiry and development are the objectives. A thorough literature analysis was carried out with an emphasis on repurposing of RLH for various diseases and analytical techniques employed in the measurement and quality control of RLH. These techniques included spectroscopic, chromatographic, and electrochemical approaches. Key advancements and trends were found by analyzing patent databases. The evaluation also looked into formulation techniques intended to improve the medicine's therapeutic efficacy and bioavailability, notably cutting-edge drug delivery methods. For the study of RLH, the review identifies several sophisticated analytical techniques that provide increased accuracy and robustness. Significant innovation has been revealed by the patent landscape, particularly in formulations targeted at enhancing solubility and bioavailability. Notable formulation techniques that overcome the drawbacks of conventional techniques include transdermal patches, nanoparticulate systems, and various drug delivery techniques.

Recent Advances in Nanotechnology-Based Drug Delivery Systems for the Diagnosis and Treatment of Reproductive Disorders

Over the past decade, nanotechnology has seen extensive integration into biomedical applications, playing a crucial role in biodetection, drug delivery, and diagnostic imaging. This is especially important in reproductive health care, which has become an emerging and significant area of research. Global concerns have intensified around disorders such as infertility, endometriosis, ectopic pregnancy, erectile dysfunction, benign prostate hyperplasia, sexually transmitted infections, and reproductive cancers. Nanotechnology presents promising solutions to address these concerns by introducing innovative tools and techniques, facilitating early detection, targeted drug delivery, and improved imaging capabilities. Through the utilization of nanoscale materials and devices, researchers can craft treatments that are not only more precise but also more effective, significantly enhancing outcomes in reproductive healthcare. Looking forward, the future of nanotechnology in reproductive medicine holds immense potential for reshaping diagnostics, personalized therapies, and fertility preservation. The utilization of nanotechnology-driven drug delivery systems is anticipated to elevate treatment effectiveness, minimize side effects, and offer patients therapies that are not only more precise but also more efficient. This review aims to delve into the various types, properties, and preparation techniques of nanocarriers specifically designed for drug delivery in the context of reproductive disorders, shedding light on the current landscape and potential future directions in this dynamic field.